Insight

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

Photo of Robert Z. Orlowski from faculty.mdanderson.org

May 4, 2024, 15:56

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day: Minimal residual disease status in multiple myeloma 1 year after autologous hematopoietic cell transplantation and lenalidomide maintenance are associated with long-term overall survival.”

Authors: Marcelo Pasquini, Paul Wallace, Brent Logan, Manmeet Kaur, Joseph Tario Jr, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy Geller, Sergio Giralt, Parameswaran Hari, Mary M. Horowitz, John Koreth, Amrita Krishnan, Heather Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan Vogl, and Theresa Hahn.

Myeloma Paper of the Day

Source: Robert Orlowski/X

Alan Howard Amrita Krishnan Brent Logan cancer Claudio Brunstein Dan Vogl Edward Stadtmauer George Somlo Heather Landau John Koreth Joseph Tario Jr Manmeet Kaur Marcelo Pasquini Mary M. Horowitz MD Anderson Cancer Center MRD in multiple myeloma multiple myeloma Myeloma Paper of the Day Nancy Geller Nina Shah OncoDaily Oncology Parameswaran Hari Paul Wallace Robert Orlowski Sergio Giralt Theresa Hahn Yali Zhang Yvonne Efebera

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer